lenalidomide has been researched along with Cancer of Testis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anusim, N; Gupta, A; Howard, G; Jaiyesimi, I | 1 |
| Kato, T; Miyao, K; Niimi, K; Ono, Y; Sakai, T; Sakemura, R; Sawa, M; Tsushita, N | 1 |
2 other study(ies) available for lenalidomide and Cancer of Testis
| Article | Year |
|---|---|
Extranodal blastoid/pleomorphic variant of mantle cell lymphoma involving the testis and skin.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Humans; In Situ Hybridization, Fluorescence; Lenalidomide; Lymphoma, Mantle-Cell; Male; Oncogene Proteins, Fusion; Orchiectomy; Positron-Emission Tomography; Prednisone; Proto-Oncogene Proteins c-myc; Radiotherapy; Rituximab; Skin Neoplasms; Testicular Neoplasms; Vincristine | 2021 |
Testicular invading refractory multiple myeloma during bortezomib treatment successfully treated with lenalidomide: a case report.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Genital Neoplasms, Male; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Neoplasm Invasiveness; Orchiectomy; Proteasome Inhibitors; Pyrazines; Secondary Prevention; Spermatic Cord; Stem Cell Transplantation; Testicular Neoplasms; Thalidomide; Vincristine | 2014 |